FDA Inspection
Columbia University Medical Center IRBColumbia University Medical Center IRB – FDA Inspection, May 31, 2017
Record Details
This FDA Inspection record concerns Columbia University Medical Center IRB, with an inspection on May 31, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c914973d-3ade-4071-ae2c-c1fa617cdd6b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012494
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.107(e)Conflict of interest
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Columbia University Medical Center IRB
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 17, 2026 | Not classified | New York District Office | |
| August 31, 2022 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| October 14, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 10, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Columbia University Medical Center IRB
- FDA Inspection 1338742 - 2026-09-17
- FDA Inspection 1178562 - 2022-08-31
- FDA Inspection 751444 - 2011-10-14
- FDA Inspection 655161 - 2010-05-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.